Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Qiuhua, Hu"'
Autor:
Qiuhua, Hu
Publikováno v:
Monumenta Serica, 2005 Jan 01. 53, 337-360.
Externí odkaz:
https://www.jstor.org/stable/40727467
Autor:
Qiuhua, Hu
Publikováno v:
Monumenta Serica, 2014 Jan 01. 62(1), 374-378.
Externí odkaz:
https://www.jstor.org/stable/26768575
Autor:
Elizabeth D. Williams, Nataly Stylianou, Katrina Sweeney, Colleen C. Nelson, Qiuhua Hu, Brett G. Hollier, Ellca Ratther, Gregor Tevz
Publikováno v:
Cancer Research. 77:818-818
Recent evidence suggests that the use of potent androgen receptor (AR) antagonists have contributed to the increased prevalence of prostate cancer (PCa) tumors exhibiting therapy resistance. Androgen targeted therapies (ATT) inhibit the androgen/AR a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98488419755dbce2fc9a9a3f9fb30195
https://doi.org/10.1158/1538-7445.am2017-818
https://doi.org/10.1158/1538-7445.am2017-818
Autor:
Brian W.C. Tse, Colleen C. Nelson, Brett G. Hollier, Katrina Sweeney, Elizabeth D. Williams, Ellca Ratther, Pamela J. Russell, Qiuhua Hu
Publikováno v:
Cancer Research. 77:2855-2855
Introduction Prostate cancer (PCa) is the second leading cause of cancer-related death in men. Initially, PCa growth and progression is primarily driven by androgen stimulation of the androgen receptor (AR). As such, the standard treatments for PCa t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbd433dd1f4ff5f12c5c60b7cd8f8d32
https://doi.org/10.1158/1538-7445.am2017-2855
https://doi.org/10.1158/1538-7445.am2017-2855